n,n-dimethylarginine has been researched along with Critical Illness in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bestle, MH; Hansen, MB; Hvid, K; Itenov, TS; Lundstrøm, LH; Mortensen, KM | 1 |
| Bruensing, J; Buendgens, L; Dückers, H; Koch, A; Kunze, J; Luedde, T; Matthes, M; Tacke, F; Trautwein, C; Weiskirchen, R | 1 |
| Brinkmann, SJ; Buijs, N; de Boer, MC; van Leeuwen, PA | 1 |
| Beckmann, B; Kayacelebi, AA; Kielstein, JT; Sitar, ME; Tsikas, D | 1 |
| Berardo, C; Di Pasqua, LG; Ferrigno, A; Richelmi, P; Vairetti, M | 1 |
| Miller, KR; Patel, JJ; Rosenthal, C; Rosenthal, MD | 1 |
| de Vries, TP; Ellger, B; Girbes, AR; Richir, MC; Siroen, MP; Spreeuwenberg, M; Teerlink, T; van den Berghe, G; van der Hoven, B; van Leeuwen, PA; Visser, M; Wilhelm, AJ | 1 |
| Davids, M; Ellger, B; Richir, MC; Teerlink, T; van den Berghe, G; van Leeuwen, PA; Visser, M | 1 |
| Davids, M; Nijveldt, RJ; Teerlink, T; van Hell, AJ; van Leeuwen, PA; Visser, M | 1 |
| Kuik, DJ; Nijveldt, RJ; Rauwerda, JA; Siroen, MP; Teerlink, T; Van Der Hoven, B; van Leeuwen, PA | 1 |
| Nijveldt, RJ; Teerlink, T; van Leeuwen, PA | 1 |
| Nijveldt, RJ; Siroen, MP; Teerlink, T; Van den Berghe, G; van Leeuwen, PA; Wouters, PJ | 1 |
| Al-Khadra, E; Castillo, L | 1 |
| Böger, RH | 1 |
4 review(s) available for n,n-dimethylarginine and Critical Illness
| Article | Year |
|---|---|
Mortality in critical illness: The impact of asymmetric dimethylarginine on survival-A systematic review and meta-analysis.
Topics: Area Under Curve; Arginine; Cause of Death; Critical Illness; Humans; Intensive Care Units; Quality Assurance, Health Care | 2019 |
Asymmetric dimethylarginine and critical illness.
Topics: Amidohydrolases; Arginine; Critical Illness; Enzyme Inhibitors; Heart Failure; Humans; Intensive Care Units; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2014 |
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury.
Topics: Animals; Arginine; Biomarkers; Critical Illness; Humans; Liver; Liver Diseases; Multiple Organ Failure; Prognosis; Risk Factors; Signal Transduction; Up-Regulation | 2015 |
When Is It Appropriate to Use Arginine in Critical Illness?
Topics: Arginine; Critical Care; Critical Illness; Dietary Supplements; Humans | 2016 |
3 trial(s) available for n,n-dimethylarginine and Critical Illness
| Article | Year |
|---|---|
Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin.
Topics: Acute Kidney Injury; Arginine; Critical Illness; Female; Humans; Male; Protein Binding; Proteolysis; Renal Dialysis; Serum Albumin; Thermolysin | 2015 |
The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.
Topics: Aged; Arginine; Critical Illness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Rosiglitazone; Thiazolidinediones | 2009 |
Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Arginine; Critical Illness; Female; Humans; Insulin; Male; Middle Aged; Morbidity; Nitric Oxide Synthase; Prospective Studies; Regression Analysis; Risk Factors; Survival Rate | 2005 |
7 other study(ies) available for n,n-dimethylarginine and Critical Illness
| Article | Year |
|---|---|
Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Sepsis; Severity of Illness Index; Survival Rate | 2013 |
Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
Topics: Amidohydrolases; Animals; Arginine; Critical Illness; Kidney; Liver; Male; Multivariate Analysis; Muscle, Skeletal; Myocardium; Rabbits; Regression Analysis | 2012 |
Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids; Arginine; Biological Transport; Blood Proteins; Chromatography, High Pressure Liquid; Critical Illness; Erythrocytes; Female; Humans; Hydrolysis; In Vitro Techniques; Male; Middle Aged; Proteasome Endopeptidase Complex; Protein Binding; Solid Phase Extraction; Young Adult | 2012 |
Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
Topics: Adult; Aged; Analysis of Variance; Arginine; Critical Illness; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Intensive Care Units; Liver Failure; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Renal Insufficiency; Risk Factors | 2003 |
The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis.
Topics: Arginine; Critical Illness; Enzyme Inhibitors; Humans; Liver; Multiple Organ Failure; Nitric Oxide | 2003 |
Hyperglycemia, asymmetric dimethylarginine, and patient survival: Dysregulation of complex networks and the metabolic basis of disease.
Topics: Arginine; Critical Illness; Homocysteine; Humans; Insulin; Nitric Oxide Synthase; Signal Transduction; Survival Rate | 2005 |
Live and let die: asymmetric dimethylarginine and septic shock.
Topics: Arginine; Critical Illness; Humans; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic | 2006 |